Holen Sie sich die Stockscreener-App
91.96
1.10%
-1.02
Handel nachbörslich:
91.96
Schlusskurs vom Vortag:
$92.98
Offen:
$93.5
24-Stunden-Volumen:
1.18M
Relative Volume:
0.67
Marktkapitalisierung:
$12.31B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$185.56M
KGV:
68.63
EPS:
1.34
Netto-Cashflow:
$517.59M
1W Leistung:
-1.07%
1M Leistung:
+4.02%
6M Leistung:
+68.80%
1J Leistung:
-0.02%
1-Tages-Spanne:
$91.83
$93.83
1-Wochen-Bereich:
$91.31
$95.22
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
91.96 | 12.44B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Here's Why Globus Medical (GMED) is a Strong Momentum Stock - sharewise.com
Y Intercept Hong Kong Ltd Cuts Position in Globus Medical, Inc. $GMED - MarketBeat
Here’s What Lifted Globus Medical (GMED) in Q4 - Insider Monkey
Globus Medical, Inc. $GMED Shares Sold by Strs Ohio - MarketBeat
Globus Medical stock operating in a buy zone after strong preliminary results - MSN
Is Globus Medical (GMED) Attractively Priced After Recent P/E And DCF Valuation Signals - Yahoo Finance
Globus Medical, Inc. (GMED) Stock Analysis: Exploring A Robust 15% Potential Upside - directorstalkinterviews.com
TD Cowen assumes coverage on Globus Medical stock with Buy rating - Investing.com Canada
What Catalysts Are Quietly Shifting The Story For Globus Medical (GMED)? - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Cuts Stock Holdings in Globus Medical, Inc. $GMED - MarketBeat
Will Globus Medical (GMED) beat estimates again in its next earnings report? - MSN
Lightrock Netherlands B.V. Increases Stock Position in Globus Medical, Inc. $GMED - MarketBeat
Aug Update: What is Globus Medical Incs TAM Total Addressable Market2025 Market Sentiment & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Spine Biologics Market Dynamics and Contributions - openPR.com
Massachusetts Financial Services Co. MA Sells 165,185 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Globus Medical (GMED) Valuation Check After Updated Guidance And NuVasive Synergy Outlook - Sahm
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report? - Finviz
Anchor Capital Advisors LLC Purchases 237,331 Shares of Globus Medical, Inc. $GMED - MarketBeat
Analysis Recap: Can Globus Medical Inc reach all time highs this yearQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
FinancialContentGlobus Medical, Inc. Class A Common Stock (NYSE:GMED) Stock Quote - FinancialContent
Should You Still Hold GMED Stock in Your Portfolio? - TradingView
Spinal Implants market to grow at a CAGR of 5.5 % during the forecast period (2025 – 2030): Wissen Research - GlobeNewswire Inc.
Globus Medical’s Higher 2025–2026 Revenue Guidance Might Change The Case For Investing In Globus Medical (GMED) - simplywall.st
The Truth About Globus Medical Inc (GMED): Is This ‘Boring’ Stock Actually a Secret Game-Changer - AD HOC NEWS
Risk On: Will Globus Medical Inc announce a stock splitJuly 2025 Final Week & Weekly High Potential Alerts - baoquankhu1.vn
Globus Medical’s blockbuster finish sets a high-stakes 2026 showdown - MSN
Stephens Investment Management Group LLC Increases Stock Position in Globus Medical, Inc. $GMED - MarketBeat
Pembroke Management LTD Sells 38,745 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (NYSE:GMED) Emerges as a Minervini-Style Growth Momentum Candidate - Chartmill
Pullback Watch: Can Globus Medical Inc reach all time highs this yearMarket Performance Report & Precise Buy Zone Identification - baoquankhu1.vn
A Look At Globus Medical (GMED) Valuation As Strong 2025 And 2026 Guidance Lifts Investor Confidence - Sahm
Is Globus Medical Inc.’s growth already priced inQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Insider Move: Kyle Kline Exercises Options, Realizing $125K At Globus Medical - Benzinga
Fed Meeting: How resilient is Globus Medical Inc stock in market downturns2025 Earnings Surprises & High Return Trade Guides - moha.gov.vn
Globus Medical (GMED) Valuation Check After Strong Q4 2025 Beat And Upgraded Sales Outlook - Yahoo Finance
Market Outlook: Can Globus Medical Inc stock hit record highs againQuarterly Portfolio Review & AI Powered Buy/Sell Recommendations - moha.gov.vn
IPO Launch: How Globus Medical Inc stock reacts to Fed rate cutsQuarterly Risk Review & Accurate Intraday Trading Signals - moha.gov.vn
Sectors Review: Will Globus Medical Inc. Class stock outperform energy sector in 2025Portfolio Return Summary & High Conviction Buy Zone Picks - Bộ Nội Vụ
Did Strong Q4 2025 Beat and Higher 2026 Sales Outlook Just Shift Globus Medical's (GMED) Investment Narrative? - Yahoo Finance
2 Healthcare Stocks to Keep an Eye On and 1 We Ignore - Barchart.com
Is Globus Medical (GMED) Priced Attractively After Recent Share Price Steadiness? - Yahoo Finance
Globus Medical (NYSE:GMED) CFO Kyle Kline Sells 3,594 Shares - MarketBeat
Kline Kyle, Globus Medical CFO, sells $363k in Gmed stock - Investing.com Canada
Globus Medical (GMED) director Norwalk sells $202k in shares By Investing.com - Investing.com India
Globus Medical (GMED) director Norwalk sells $202k in shares - Investing.com
Globus Medical (NYSE:GMED) Director Sells $202,200.00 in Stock - MarketBeat
Globus Medical Insider Sold Shares Worth $363,353, According to a Recent SEC Filing - marketscreener.com
Why Globus Medical (GMED) Is Up 8.2% After Raising 2026 Revenue Guidance And Integration Outlook - simplywall.st
Stifel maintains GMED buy rating, $92 target amid NVRO buyout - MSN
Audubon’s Globus Medical Wins $9.5 Million Settlement - MSN
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):